Cooper Companies | COO - Equity Capital And Reserves


Cooper Companies reported $8.36B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Abbott USD 52.06B 69M Mar/2026
Align Technology USD 4.15B 100.27M Mar/2026
AtriCure USD 491.69M 242K Mar/2026
Avanos Medical USD 782.1M 3.9M Mar/2026
Bausch Health Companies USD -2.06B 1.5B Mar/2026
Baxter International USD 6.04B 86M Mar/2026
Bayer EUR 28.85B 2.9B Mar/2026
Becton, Dickinson and Co. USD 24.13B 1.15B Mar/2026
Boston Scientific USD 25.86B 1.63B Mar/2026
Cooper Companies USD 8.36B 124.7M Dec/2025
Dentsply International USD 1.32B 21M Mar/2026
Dexcom USD 2.96B 210.9M Mar/2026
Edwards Lifesciences USD 10.33B 10.1M Mar/2026
Globus Medical USD 4.73B 159.06M Mar/2026
Haemonetics USD 796.32M 115.13M Mar/2026
Inogen USD 197.18M 2.32M Sep/2025
Insulet USD 1.3B 212.6M Mar/2026
Integra LifeSciences USD 1.04B 1.06M Mar/2026
Intuitive Surgical USD 17.47B 349.5M Mar/2026
J&J USD 81.19B 358M Mar/2026
Medtronic USD 48.99B 128M Dec/2025
Merit Medical Systems USD 1.63B 42.42M Mar/2026
Novartis USD 46.13B 1.8B Dec/2025
ResMed USD 6.49B 171.03M Mar/2026
STAAR Surgical USD 352.37M 8.18M Mar/2026
Steris USD 7.18B 29.1M Mar/2026
Stryker USD 22.42B 635M Dec/2025
Tandem Diabetes Care USD 132.4M 22.77M Mar/2026
Teleflex USD 3.08B 40.33M Mar/2026
Utah Medical Products USD 119.27M 1.02M Dec/2025
Zimmer Biomet Holdings USD 12.68B 16.1M Mar/2026